Freemelt AB, based in Sweden, has secured a significant partnership with a leading global orthopaedic implant OEM. This collaboration aims to demonstrate the serial production capabilities of Freemelt’s eMELT Electron Beam Powder Bed Fusion (PBF-EB) Additive Manufacturing (AM) system. The partnership will culminate in the installation of the eMELT machine at the OEM’s production facility in Q2 2025 for a proof-of-concept project.
eMELT System: Revolutionizing Titanium Implant Production
Freemelt’s eMELT system is transforming the manufacturing process for titanium-based orthopaedic implants. Titanium’s strength, biocompatibility, and durability make it ideal for joint replacement surgeries. The demand for additive-manufactured implants is rapidly growing and is expected to reach $6.6 billion by 2032. The eMELT system provides a high-productivity, efficient solution that meets the increasing demand for titanium implants. It plays a key role in improving the production processes, driven by factors such as aging populations and the rising need for joint replacements.
Freemelt’s Expertise in Additive Manufacturing
Beyond providing the eMELT system, Freemelt offers valuable expertise in the PBF-EB technology. This collaboration includes process and application engineering support, enabling the OEM to enhance production efficiency and innovation. With Freemelt’s advanced manufacturing capabilities, the OEM is poised to make significant strides in improving orthopaedic implant production.
Conclusion
The partnership between Freemelt and the global orthopaedic implant OEM marks a crucial step in the evolution of additive manufacturing. As the demand for titanium implants rises, the eMELT system will play a central role in meeting this need. Freemelt’s commitment to advancing production efficiency and providing expert support further solidifies its position as a leader in the additive manufacturing industry.
Leave a Reply
You must be logged in to post a comment.